Human T-lymphotropic virus type 1 oncoprotein tax promotes S-phase entry but blocks mitosis

Journal of Virology
Min-Hui LiangChou-Zen Giam

Abstract

Human T-lymphotropic virus type 1 (HTLV-1) Tax exerts pleiotropic effects on multiple cellular regulatory processes to bring about NF-kappaB activation, aberrant cell cycle progression, and cell transformation. Here we report that Tax stimulates cellular G(1)/S entry but blocks mitosis. Tax expression in naive cells transduced with a retroviral vector, pBabe-Tax, leads to a significant increase in the number of cells in the S phase, with an accompanying rise in the population of cells with a DNA content of 4N or more. In all cell types tested, including BHK-21, mouse NIH 3T3, and human diploid fibroblast WI-38, Tax causes an uncoupling of DNA synthesis from cell division, resulting in the formation of multinucleated giant cells and cells with decondensed, highly convoluted and lobulated nuclei that are reminiscent of the large lymphocytes with cleaved or cerebriform nuclei seen in HTLV-1-positive individuals. This contrasts with the Tax-transformed cell lines, PX1 (fibroblast) and MT4 (lymphocyte), which produce Tax at high levels, but without the accompanying late-stage cell cycle abnormalities. PX1 and MT4 may have been selected to harbor somatic mutations that allow a bypass of the Tax-induced block in mitosis.

References

Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·L J Zhao, C Z Giam
Sep 11, 1987·Science·S H HinrichsG Jay
Oct 1, 1994·AIDS Research and Human Retroviruses·K F CopelandJ L Heeney
Feb 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·W J GrossmanL Ratner
Sep 27, 1994·Proceedings of the National Academy of Sciences of the United States of America·J K YeeT Friedmann
Aug 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·A P ArmstrongJ K Nyborg
May 15, 1997·Oncogene·K ChlichliaK Khazaie
May 14, 1999·Trends in Biochemical Sciences·T A MillwardB A Hemmings

❮ Previous
Next ❯

Citations

Sep 13, 2005·Oncogene·Susan J Marriott, Oliver John Semmes
Sep 13, 2005·Oncogene·Ralph GrassmannKuan-Teh Jeang
Nov 29, 2007·Journal of Clinical Pathology·G Taylor
Apr 6, 2006·The Journal of Clinical Investigation·David SibonEric Wattel
Apr 6, 2006·The Journal of Clinical Investigation·O John Semmes
Aug 16, 2008·Retrovirology·Mathieu BoxusLuc Willems
Feb 2, 2008·Retrovirology·James M Bogenberger, Paul J Laybourn
Jan 10, 2012·Retrovirology·Mathieu Boxus, Luc Willems
Sep 19, 2007·International Journal of Hematology·Jean-Marie PeloponeseKuan-Teh Jeang
Oct 14, 2011·Viruses·Julie LodewickFrançoise Bex
Dec 21, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jean-Marie PeloponeseKuan-Teh Jeang
Dec 30, 2004·Proceedings of the National Academy of Sciences of the United States of America·Baoying LiuChou-Zen Giam
Jun 26, 2012·Trends in Microbiology·Min MoAndrew A Mercer
Jun 19, 2010·Chemico-biological Interactions·Katerina Chlichlia, Khashayarsha Khazaie
Dec 17, 2014·Virus Research·Wei JiCheng-Qiang He
Nov 18, 2017·Annual Review of Immunology·Charles R M Bangham
May 4, 2018·The FEBS Journal·Edward William Harhaj, Chou-Zen Giam
Jan 22, 2005·The Journal of Biological Chemistry·Timothy AlefantisBrian Wigdahl
Apr 8, 2006·The EMBO Journal·Yu-Liang Kuo, Chou-Zen Giam
Mar 16, 2007·The Journal of Biological Chemistry·Uma Sinha-DattaChristophe Nicot
Aug 14, 2019·Reviews in Medical Virology·Fateme TaheriEbrahim Faghihloo

❮ Previous
Next ❯

Related Concepts

Related Feeds